Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 389 | 886 | 451 | 398 | 201 |
| Operating Income | -389 | -886 | -451 | -398 | -201 |
| Other Income | 3,163 | 1,134 | 6,110 | -3,627 | 6,520 |
| Pre-tax Income | 2,773 | 248 | 5,659 | -4,025 | 6,319 |
| Net Income Continuous | 2,773 | 248 | 5,659 | -4,025 | 6,319 |
| Net Income | $2,773 | $248 | $5,659 | $-4,025 | $6,319 |
| EPS Basic Total Ops | 5.76 | -5.04 | 11.51 | -8.63 | 20.86 |
| EPS Basic Continuous Ops | 28.92 | 3.75 | 59.00 | -41.97 | 65.89 |
| EPS Diluted Total Ops | 5.76 | -5.04 | 11.51 | -8.63 | 20.86 |
| EPS Diluted Continuous Ops | 28.92 | 3.75 | 59.00 | -41.97 | 65.89 |
| EBITDA(a) | $-389 | $-886 | $-451 | $-398 | $-201 |